Variant report
Variant | nsv524085 |
---|---|
Chromosome Location | chr8:4812436-4816030 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7815832 | chr8:4812436-4812437 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs554056133 | chr8:4812438-4812439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566291489 | chr8:4812446-4812447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376390324 | chr8:4812498-4812499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs6558947 | chr8:4812519-4812520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575907669 | chr8:4812534-4812535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537655043 | chr8:4812541-4812542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543019490 | chr8:4812556-4812557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs13282812 | chr8:4812557-4812558 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs577478646 | chr8:4812566-4812567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573615947 | chr8:4812567-4812568 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540962991 | chr8:4812583-4812584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs6988561 | chr8:4812593-4812594 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs545933608 | chr8:4812602-4812603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185289262 | chr8:4812648-4812649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs76475561 | chr8:4812649-4812650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs373271115 | chr8:4812656-4812657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs13261975 | chr8:4812661-4812662 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs550212142 | chr8:4812669-4812670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs191186766 | chr8:4812676-4812677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs368509232 | chr8:4812680-4812681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372790508 | chr8:4812684-4812685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs375483060 | chr8:4812692-4812693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs183394573 | chr8:4812708-4812709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs6558948 | chr8:4812710-4812711 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs141533079 | chr8:4812711-4812712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187195335 | chr8:4812729-4812730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs569436245 | chr8:4812750-4812751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551018619 | chr8:4812752-4812753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536617701 | chr8:4812754-4812755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs13269761 | chr8:4812767-4812768 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
32 | rs146170822 | chr8:4812779-4812780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191672100 | chr8:4812780-4812781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs139084480 | chr8:4812802-4812803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs577714177 | chr8:4812803-4812804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10081536 | chr8:4812812-4812813 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs77293935 | chr8:4812823-4812824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs149916302 | chr8:4812824-4812825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552224458 | chr8:4812840-4812841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565671329 | chr8:4812842-4812843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs7463075 | chr8:4812859-4812860 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs371283034 | chr8:4812868-4812869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548259862 | chr8:4812877-4812878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529346311 | chr8:4812878-4812879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368532569 | chr8:4812922-4812923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183536798 | chr8:4812933-4812934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs568170248 | chr8:4812940-4812941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs559999042 | chr8:4812946-4812947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs373701682 | chr8:4812979-4812980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533336918 | chr8:4812982-4812983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Breast cancer | 21364760 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:4811200-4813000 | Enhancers | Adipose Nuclei | Adipose |
2 | chr8:4811800-4813600 | Enhancers | Liver | Liver |
3 | chr8:4815200-4815800 | Enhancers | Fetal Brain Male | brain |
4 | chr8:4815800-4818000 | Weak transcription | Fetal Brain Male | brain |